TUDOR INVESTMENT CORP ET AL

Position in RVMD — Revolution Medicines, Inc.

CIK 923093 STAMFORD, CT

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,543,607

+$1,184,664 QoQ

Shares Held

87,852

-4.9% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $331,863,418 across 116 Biotechnology names. RVMD ranks #8 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	462,588	$53,114,354
2	RPRX	Royalty Pharma plc	671,680	$32,220,489
3	XENE	Xenon Pharmaceuticals Inc.	495,591	$28,818,616
4	APLS	Apellis Pharmaceuticals, Inc.	650,000	$26,149,500
5	TERN	Terns Pharmaceuticals, Inc.	267,520	$14,103,654
6	FOLD	AMICUS THERAPEUTICS, INC.	900,000	$13,014,000
7	ABVX	Abivax S.A.	101,611	$11,314,384
8	RVMD	Revolution Medicines, Inc. This page	87,852	$8,543,607

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,543,607	87,852	-4.9%	Shares	Defined	2026-05-15
2025-12-31	$7,358,943	92,391	+162.6%	Shares	Defined	2026-02-17
2025-06-30	$1,294,456	35,185	-8.1%	Shares	Defined	2025-08-14
2024-09-30	$1,737,177	38,306	+182.0%	Shares	Defined	2024-11-14
2023-06-30	$363,345	13,583	+0.5%	Shares	Defined	2023-08-14
2023-03-31	$292,713	13,514	+43.2%	Shares	Defined	2023-05-15
2022-12-31	$224,836	9,439	-59.0%	Shares	Defined	2023-02-14
2022-06-30	$448,231	22,998	-66.0%	Shares	Defined	2022-08-15
2022-03-31	$1,727,562	67,721	-10.7%	Shares	Defined	2022-05-16
2021-06-30	$2,405,796	75,797	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.